ELAN Return on Tangible Equity | Elanco Animal Health Incorporated

Elanco Animal Health Incorporated (ELAN) Return on Tangible Equity

2026-06-30: Return Tang Equity 12.01%.
2026-03-31: Return Tang Equity 14.91%.
2025-12-31: Return Tang Equity 14.22%.
2025-09-30: Return Tang Equity -2.56%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	12.01%
2026-03-31	14.91%
2025-12-31	14.22%
2025-09-30	-2.56%
2025-06-30	-31.61%
2025-03-31	-24.14%
2024-12-31	-19.79%
2024-09-30	-9.12%
2024-06-30	46.74%
2024-03-31	50.68%
2023-12-31	40.79%
2023-09-30	35.25%
2023-06-30	3.65%
2023-03-31	0.85%
2022-12-31	2.45%
2022-09-30	3.06%
2022-06-30	4.21%
2022-03-31	9.82%
2021-12-31	12.36%
2021-09-30	14.77%
2021-06-30	16.25%
2021-03-31	13.56%
2020-12-31	14.07%
2020-09-30	47.01%
2020-06-30	-8.63%
2020-03-31	-1.02%
2019-12-31	56.67%
2019-09-30	167.20%
2019-06-30	-80.31%
2019-03-31	-20.40%
2018-12-31	-35.13%
2018-09-30	22.44%
2018-06-30	-8.48%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	14.22%
2024-12-31	-19.79%
2023-12-31	40.79%
2022-12-31	2.45%
2021-12-31	12.44%
2020-12-31	14.07%
2019-12-31	56.67%
2018-12-31	-35.13%
2017-12-31	-13.90%
2016-12-31	-0.68%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05